MedTrace Logo

EEG Alpha/Theta Neurofeedback to Reduce Trait Anxiety

NCT02964520 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2017-01-05

No results posted yet for this study

Summary

This study evaluates if individuals with moderate to high trait anxiety can learn how to self-regulate their brain waves and reduce their trait anxiety in ten sessions of EEG alpha-theta neurofeedback training. Half of the randomly assigned participants will receive alpha/theta neurofeedback training while the other half will receive a two-part control protocol where low beta and beta waves will be uptrained in and downtrained in in successive sessions.

Conditions

Interventions

BEHAVIORAL

Neurofeedback training

uptraining alpha (8-11 Hz) and theta (5-7.5 Hz) frequency bands, inhibiting beta (15-30 Hz) and delta (2-4 Hz)

BEHAVIORAL

Sham comparator: Sham neurofeedback training

in UNEVEN neurofeedback sessions (1,3,5,7,9): up-training lobeta (13-16 Hz) and hibeta (16-22 Hz), inhibiting alpha (8-11 Hz), theta (5-7.5 Hz) and hibeta (23-30 Hz) in EVEN neurofeedback sessions (2,4,6,8,10): down-training beta (13-16 Hz) and hibeta (16-22 Hz), inhibiting alpha (8-11 Hz), theta (5-7.5 Hz) and hibeta (23-30 Hz)

Sponsors & Collaborators

  • University of Hartford

    lead OTHER

Principal Investigators

  • Bettina Viereck, Dipl-Psych · University of Hartford, Department of Psychology

  • Ute Strehl, Ph.D.; Dipl.-Psych. · University of Tuebingen, Institute for Medical Psychology and Behavioural Neurobiology, Germany

  • Boris Kotchoubey, Ph.D.; M.D. · University of Tuebingen, Institute for Medical Psychology and Behavioural Neurobiology, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02964520 on ClinicalTrials.gov